Table 1.
Clinical summary of patients with lacrimal adenoid carcinoma treated with neoadjuvant intra-arterial chemotherapy
| Age (years)/sex | Histological diagnosis | Location | NAIC | Surgery | Complications | Recurrence/metastasis | Outcome | |
|---|---|---|---|---|---|---|---|---|
| CASE 1 |
35/F |
Cribriform-like ACC |
Right orbit |
2 cycles |
Total exenteration |
Ipsilateral eyelid and eyeball necrosis, permanent facial palsy |
No |
Survival |
| CASE 2 |
54/F |
Tubular pattern ACC |
Right orbit |
3 cycles |
Total exenteration |
Facial swelling and tenderness, difficulties in chewing |
No |
Survival |
| CASE 3 |
45/F |
Cribriform-like ACC |
Right orbit |
1 cycle |
Total exenteration |
Febrile neutropenia, cellulitis |
No |
Survival |
| CASE 4 | 75/M | ACC | Right orbit | 3 cycles | Tumour resection only | Neutropenia, thrombocytopenia | Local recurrence | Survival |
F, female; M, male; ACC, adenoid cystic carcinoma; NAIC, neoadjuvant intra-arterial chemotherapy.